Cargando…
Differential BDNF Responses of Triple Versus Dual Reuptake Inhibition in Neuronal and Astrocytoma Cells as well as in Rat Hippocampus and Prefrontal Cortex
Monoamine reuptake inhibitors increase brain-derived neurotrophic factor (BDNF) activity, and this growth factor is regarded as an interesting target for developing new antidepressant drugs. The aims of this study were to evaluate whether monoaminergic reuptake inhibition increases BDNF in vivo and...
Autores principales: | Prickaerts, Jos, De Vry, Jochen, Boere, Janneke, Kenis, Gunter, Quinton, Maria S., Engel, Sharon, Melnick, Larry, Schreiber, Rudy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Humana Press Inc
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413810/ https://www.ncbi.nlm.nih.gov/pubmed/22581450 http://dx.doi.org/10.1007/s12031-012-9802-9 |
Ejemplares similares
-
BDNF Protein and BDNF mRNA Expression of the Medial Prefrontal Cortex, Amygdala, and Hippocampus during Situational Reminder in the PTSD Animal Model
por: Chang, Shao-Han, et al.
Publicado: (2021) -
Triple Reuptake Inhibitors: The Next Generation of Antidepressants
por: Marks, David M, et al.
Publicado: (2008) -
Triple Reuptake Inhibitors: A Premise and Promise
por: Marks, David M., et al.
Publicado: (2008) -
Translational Issues with the Development of Cognition Enhancing Drugs
por: Blokland, Arjan, et al.
Publicado: (2014) -
Postnatal BDNF Expression Profiles in Prefrontal Cortex and Hippocampus of a Rat Schizophrenia Model Induced by MK-801 Administration
por: Guo, Chunmei, et al.
Publicado: (2010)